# Codex Master Backlog Amendment A — Airline + Healthcare Corpora (Codex-Authored)

**Date:** 2026-05-29
**Author:** AbarVa Founder + Claude
**Status:** Proposed
**Amends:** `docs/build/CODEX_MASTER_BACKLOG_2026-05-29.md`

---

## Why this amendment exists

The original Founder Master Backlog Section 6 sequenced industry overlays after retail validates, with founder + Claude pair-authoring as the throughput-limiting step (~30-40 founder hours across airline + healthcare-provider + healthcare-medtech).

**Founder decision 2026-05-29:** Skip founder pair-authoring for the airline + healthcare overlays. Codex (with Claude / GPT-class authoring assistance) authors the patterns directly against explicit quality guardrails. Customer extensibility + paid custom-authoring becomes the strategic upsell.

This amendment:
- Adds Section 5A (airline extension), Section 5B (healthcare provider), Section 5C (healthcare medtech) to Codex's critical-path scope
- Bakes in explicit quality guardrails to compensate for absent founder voice
- Establishes provenance tagging so future audits distinguish founder-authored vs Codex-authored patterns
- Adds Section 11.5 — Customer Custom Pattern Authoring as a future capability + revenue SKU

---

## Section 5A — Airline Corpus Extension (Codex-authored)

### Scope
Extend the existing airline pattern overlay (`docs/build/delta-pilot/AIRLINE_INDUSTRY_PATTERN_OVERLAY_v1.md`, ~184 packs / 2,760 patterns) to ≥5,500 patterns across ≥60 super-categories matching the retail corpus structure (Packet 35 Tier A/B/C/D).

### Existing baseline
- ~184 packs / ~2,760 patterns covering core airline operations, modernization, AI, sourcing
- Authored by founder + Claude in earlier session (Packet 31)
- Already validated against SkyHarbor tenant; expert-consultant-grade for the topics covered

### Net new authoring
~2,500–2,700 new patterns across 3 sub-waves:

#### Wave 5A.1 — Airline format verticals (~800 patterns)
Apply Packet 35 Tier B pattern to airline. Format verticals to cover:
- Network carriers (legacy + flag carriers)
- Low-cost carriers (Ryanair/Spirit-shape)
- Ultra-low-cost carriers
- Regional carriers
- Charter operations
- Cargo-only operators
- Hybrid / business-class-only carriers
- Joint-venture / antitrust-immunized operations

Each format vertical: ~100 patterns covering economics, operating model, technology stack, fleet strategy, regulatory posture, competitive dynamics, sourcing patterns.

#### Wave 5A.2 — Adjacent industries (~900 patterns)
Apply Packet 35 Tier C pattern to airline-adjacent. Adjacencies to cover:
- Aircraft OEMs (Boeing, Airbus, Embraer ecosystem — anonymized)
- Engine OEMs (GE, RR, Pratt — anonymized)
- MRO providers
- Aviation finance and leasing (lessors as supply chain)
- Airport authorities and ground handlers
- GDS / distribution
- IFE (in-flight entertainment) suppliers
- Aviation insurance
- Air cargo brokers and freight forwarders
- ATC modernization (NextGen, SESAR)
- Sustainable aviation fuel ecosystem
- Aerospace defense adjacency

#### Wave 5A.3 — Cross-cutting depth (~800 patterns)
Deepen Tier D coverage with airline-specific lenses:
- Airline finance (PRASM/CASM/RASM unit economics)
- Airline M&A (DL-NW, AA-US, UA-CO playbook patterns)
- Airline cybersecurity (PCI, IATA, IFE attack surface)
- Airline regulatory (FAA, EASA, IATA, bilateral air services agreements)
- Airline sustainability (SAF, fleet renewal, scope 1/2/3)
- Airline workforce (pilot/crew/AMT scarcity, GCC patterns)
- Airline disruption recovery (IROPs playbooks)

### Quality guardrails (compensating for absent founder voice)

Each pattern must meet:

**Source material policy:**
- Cite publicly-available source category: industry analyst report (Skytrax, IATA, Bain, McKinsey, OAG), public 10-K / annual report, regulatory filing, industry press
- No founder anecdotal claims (because no founder voice)
- No fabricated specifics — every quantified claim is either (a) a public-domain industry number or (b) explicitly framed as "industry-typical range"

**Vocabulary fluency:**
- Use airline-specific vocabulary precisely (PRASM not "revenue per seat"; codeshare not "partner"; FRIA not "ATC pause")
- Anchor against the existing 2,760-pattern baseline for tone

**Anonymization:**
- "US3 legacy carriers" or "European JV trio" or "Gulf3 super-connectors" — not "Delta" or "Emirates"
- Industry exemplars reference anonymous tiers, not named entities

**Pitfall-aware:**
- Every pattern names ≥1 failure mode
- Counter-intuitive reasoning preserved: "this works UNLESS [condition]"

**Provenance tagging (NEW):**
Every pattern row in `corpus_patterns` includes:
```
provenance: {
  source: "codex_authored",
  authoring_model: "claude-sonnet-X | gpt-X",
  authoring_session: "<session-id>",
  founder_reviewed: false,
  customer_authored: false,
  industry_advisor_reviewed: false,
  quality_tier: "codex_v1"
}
```

This makes audit-time differentiation explicit: "founder-authored" vs "Codex-authored" vs "customer-authored" (future) vs "advisor-reviewed" (future). Customers and investors can query the breakdown.

### Validation

Same 5-test expert-consultant gauntlet from Packet 35 §6.1 Step 7:
1. Vocabulary fluency
2. Vendor landscape depth
3. Time-horizon awareness
4. Peer benchmarking specificity
5. Counter-intuitive reasoning

**Adjusted pass threshold:** ≥3/5 (vs ≥4/5 for founder-authored). Acknowledges that Codex-authored patterns will be measurably-but-acceptably weaker on counter-intuitive reasoning specifically.

If ≥3/5 fails: Codex iterates the failing dimension's patterns before merging the wave. Doesn't escalate to founder unless three iteration attempts fail.

### Output structure

```
docs/build/industry-overlays/airline/
├── AIRLINE_OVERLAY_v2_MASTER_INDEX.md         # Updated index w/ baseline + new
├── AIRLINE_OVERLAY_v2_WAVE_A1_FORMAT_VERTICALS.md
├── AIRLINE_OVERLAY_v2_WAVE_A2_ADJACENT_INDUSTRIES.md
├── AIRLINE_OVERLAY_v2_WAVE_A3_CROSS_CUTTING_DEPTH.md
└── AIRLINE_OVERLAY_v2_CONSOLIDATED.md          # Final merged
```

### Sequencing

- **Gate:** Retail Wave 5 closes (`core/` cross-industry extraction complete) AND retail validation gauntlet passes
- **Parallel-OK:** Yes — Wave 5A.1, 5A.2, 5A.3 can author in parallel (independent thematic scope)
- **Authority class:** D (auto-merge per wave under trust ladder business-hours rule, with founder spot-check at wave boundaries)

### Acceptance

- [ ] ≥5,500 total airline patterns (baseline 2,760 + new ~2,700)
- [ ] ≥60 super-categories
- [ ] All new patterns tagged with codex_authored provenance
- [ ] Validation gauntlet ≥3/5
- [ ] SkyHarbor verifier ≥22/25 with airline-extended overlay loaded
- [ ] Cross-tenant isolation preserved (airline overlay invisible to Apex / Meridian / Northstar / First Capital)

### Effort estimate
- Codex authoring: ~3–5 days elapsed across 3 parallel waves
- Founder spot-check: 30–60 min per wave (~3 hours total — vs the original 12-15 hour estimate)
- Validation: 1 day

---

## Section 5B — Healthcare Provider Corpus (Codex-authored, no advisor for v1)

### Scope
Author healthcare-provider industry overlay from scratch. Target ≥2,500 patterns across ≥40 super-categories. Tagged `industry = healthcare_provider`.

### Tenant target
Meridian Health (canonical T1 demo tenant). Future: PHS pilot, future hospital-system customers.

### Wave structure (~2,500 patterns across 3 sub-waves)

#### Wave 5B.1 — Care delivery + operations (~900 patterns)
- Patient care delivery (acute, ambulatory, ED, OR)
- Care management and pathways
- Quality and safety (NPSGs, never-events, HCAHPS)
- Clinical operations
- Pharmacy operations
- Imaging and diagnostics
- Inpatient operations (LOS, throughput, readmissions)
- Outpatient and ambulatory
- ED operations and disposition

#### Wave 5B.2 — Revenue, sourcing, and IT estate (~800 patterns)
- Revenue cycle (claims, denials, reimbursement)
- Payer contracting and negotiations
- Population health and risk
- Value-based care (ACO, capitation, bundles)
- Provider sourcing and supply chain
- Health IT estate (Epic / Cerner / Meditech / Allscripts patterns)
- Interoperability (FHIR, HL7, CommonWell, Carequality)
- AI in healthcare (clinical AI, ambient documentation, admin AI)

#### Wave 5B.3 — Strategic, regulatory, and cross-cutting (~800 patterns)
- Healthcare regulatory (HIPAA, HITECH, MACRA, CMS, state)
- Healthcare cybersecurity (PHI exposure, ransomware patterns)
- Workforce (nursing shortage, provider burnout, scope-of-practice)
- Patient experience
- Healthcare finance (margins, charity care, 340B)
- Healthcare M&A (system consolidation, payvider integration)
- Emerging (hospital-at-home, AI scribes, virtual care)
- Healthcare board governance and strategic planning

### Quality guardrails

Same as Section 5A plus healthcare-specific:

**Regulatory accuracy:**
- HIPAA references must be technically precise (Privacy Rule vs Security Rule; Safe Harbor de-identification; BAA vs DPA distinctions)
- CMS programs cited correctly (MIPS / APMs / MA Star Ratings)
- Joint Commission and state regulatory framings precise

**Vendor accuracy:**
- Epic / Cerner / Meditech / Allscripts positioning correct
- Imaging vendor landscape correct (GE Healthcare, Philips, Siemens Healthineers, Canon Medical)
- Specialty pharmacy and PBM dynamics accurate

**Care-pathway specificity:**
- Disease state references (CHF, CKD, oncology, behavioral health) use clinically precise terminology
- Care management workflows reference standard taxonomies (MEPS, CCM, TCM, RPM)

**Provenance:** same `codex_authored` tagging as Section 5A.

### Validation
- 5-test gauntlet adapted for healthcare-provider (e.g., Test 1 = "VBC vs FFS distinction" not "shrink vs ORC")
- Adjusted pass threshold ≥3/5
- Meridian verifier ≥18/25 (lower bar than expert-consultant gauntlet because Meridian substrate isn't healthcare-deep yet)

### Output
```
docs/build/industry-overlays/healthcare-provider/
├── HEALTHCARE_PROVIDER_OVERLAY_v1_MASTER_INDEX.md
├── HEALTHCARE_PROVIDER_OVERLAY_v1_WAVE_B1_CARE_DELIVERY_OPS.md
├── HEALTHCARE_PROVIDER_OVERLAY_v1_WAVE_B2_REVENUE_SOURCING_IT.md
├── HEALTHCARE_PROVIDER_OVERLAY_v1_WAVE_B3_STRATEGIC_REG_CROSS.md
└── HEALTHCARE_PROVIDER_OVERLAY_v1_CONSOLIDATED.md
```

### Sequencing
- **Gate:** Section 5A closes + Apex foundation validated (provides confidence that the Codex-authored methodology works at scale)
- **Parallel-OK:** Internal wave parallelism (Yes)
- **Authority class:** D + founder spot-check per wave
- **Special note:** When healthcare advisor onboards (Founder Backlog Section 1.5), a separate amendment will queue Wave 5B.4 (advisor-reviewed revision pass) — does NOT block initial v1 release

### Effort estimate
- Codex authoring: ~3–4 days elapsed
- Founder spot-check: ~2 hours total
- Validation: 1 day

---

## Section 5C — Healthcare Medtech Corpus (Codex-authored, sequenced after 5B)

### Scope
Author healthcare-medtech (Solventum-shape) industry overlay from scratch. Target ≥2,000 patterns across ≥35 super-categories. Tagged `industry = healthcare_medtech`.

### Tenant target
Northstar Clinical Technologies. Future: any medtech / medical-products / device manufacturer customer.

### Wave structure (~2,000 patterns across 2 sub-waves)

#### Wave 5C.1 — Medtech operations + commercial (~1,000 patterns)
- Medtech R&D and product development
- Manufacturing operations (FDA-regulated facilities)
- Quality management (ISO 13485, FDA QSR, EU MDR)
- Supply chain (component sourcing, contract manufacturing)
- Commercial operations (hospital sales, GPO contracts)
- Distribution and channel partnerships
- Service and field engineering
- Pricing and reimbursement (CMS code coverage, payer policies)
- Customer success in medtech (clinical training, install base management)

#### Wave 5C.2 — Strategic, regulatory, and emerging (~1,000 patterns)
- Medtech regulatory (FDA 510(k), De Novo, PMA, EU MDR, FDA AI/ML guidance)
- Post-market surveillance and MDR (Medical Device Reporting)
- Clinical trials and evidence generation
- IP strategy in medtech
- Medtech M&A (J&J / Medtronic / Stryker patterns — anonymized)
- AI in medtech (image analysis, clinical decision support, FDA AI pathway)
- Digital health and connected devices
- Medtech finance and unit economics
- Medtech cybersecurity (FDA premarket cyber, OT/IoT)
- Healthcare medtech sustainability (single-use vs reprocessing)

### Quality guardrails
Same as Section 5A + 5B with medtech-specific additions:

**FDA accuracy:**
- 510(k) vs De Novo vs PMA distinctions precise
- AI/ML predetermined change control plan (PCCP) referenced correctly
- 21 CFR Part 820 and Part 803 specifically called out where relevant

**Reimbursement specificity:**
- CMS code categories (CPT, HCPCS, DRG) used precisely
- Payer coverage process (LCDs, NCDs, prior auth)

### Validation
- 5-test gauntlet adapted for healthcare-medtech
- Pass threshold ≥3/5
- Northstar verifier ≥18/25

### Sequencing
- **Gate:** Section 5B closes + Northstar substrate refreshed if needed
- **Parallel-OK:** Internal wave parallelism
- **Authority class:** D + founder spot-check

### Effort estimate
- Codex authoring: ~2–3 days elapsed
- Founder spot-check: ~1 hour
- Validation: 1 day

---

## Updated total corpus state after Sections 5, 5A, 5B, 5C

| Industry | Patterns | Origin |
|---|---|---|
| `cross_industry` (core) | ~450 | Extracted from retail Wave 5 |
| `retail` | ~5,500 | Codex-authored Waves 1-5 |
| `airline` | ~5,500 | Founder-baseline 2,760 + Codex-extended 2,700 |
| `healthcare_provider` | ~2,500 | Codex-authored |
| `healthcare_medtech` | ~2,000 | Codex-authored |
| `financial_services_banking` | future | Deferred |
| **Total** | **~15,950** | **Across 4 active verticals** |

That is the moat-defensible substrate. The investor pitch becomes:

> *"AbarVa has industrialized industry-pattern authoring at ~5,000 patterns per vertical. We have 4 verticals live: retail, airline, healthcare-provider, healthcare-medtech, with banking sequenced next. Customer extensibility built in: clients can author their own patterns OR commission custom authoring through our Professional Services lane. Competitors building decision-intelligence platforms would need 18-24 months to reach equivalent depth across a single vertical."*

---

## Section 11.5 — Customer Custom Pattern Authoring (future capability + revenue SKU)

This is the strategic positioning that makes Codex-authored patterns defensible commercially.

### The pitch to customers
> "Our industry overlay covers ~5,000 patterns of your vertical out of the box. As you mature on the platform, you can:
>
> (a) **Author your own custom patterns** through the customer admin UI — your private patterns, scoped to your tenant only via `client_private_patterns` table per ADR-0001. Included in your platform fee.
>
> (b) **Commission AbarVa-authored custom patterns** at our Professional Services rate ($475/hr partner, $325/hr architect, $250/hr senior consultant per Packet 31 §3.6 rate card). Typical scope: 50-200 custom patterns specific to your competitive landscape, regulatory posture, or proprietary methodology. ~1-3 weeks elapsed per engagement."

### Why this works commercially
- **Hedges quality concerns:** customer can fill gaps Codex authored couldn't catch
- **Creates upsell motion:** custom pattern authoring is a new revenue line
- **Strengthens moat:** customer's private patterns are a switching cost
- **Justifies platform fee:** the out-of-box overlay is the proof; customization is the value-add
- **Investor signal:** demonstrates land-and-expand mechanics built in from day 1

### Capability gates
- `client_private_patterns` table already exists (per ADR-0001 §D.2)
- Tenant overlay subscriptions support per-customer private patterns
- Customer admin Phase 1 (Packet 32 C4 P0) read-only doesn't yet include custom pattern authoring UI

### Sequencing
- v1: Verbal positioning in PHS / Delta sales conversations (now)
- v2: Customer admin UI for private pattern authoring (Packet 32 C4 Phase 2, post first paying customer)
- v3: Professional Services standardized SKU with pricing card (Founder Backlog Section 14.4)

### Authority class
- v1 verbal positioning: founder
- v2 admin UI: Codex (class E new feature)
- v3 PS SKU: founder + legal

---

## Trust ladder implications

Codex authoring patterns at scale (15,000+) with founder spot-check only at wave boundaries is a meaningful authority extension. Specifically:

- **Pattern authoring** historically was class E (architecture-affecting) per Packet 31 §4.3 — required founder approval before authoring
- **This amendment authorizes class D + spot-check** for content authoring against the established 5-pattern format contract

**Rationale:** the format contract is deterministic. The reusability moat is in the format (every pattern has summary/mechanism/decision relevance/pitfalls/exemplars/provenance). The quality bar is the 5-test gauntlet which can be Codex-administered. Founder spot-check at wave boundaries (30-60 min per wave) catches systematic drift without bottlenecking authoring throughput.

**Reversion clause:** if any wave fails 5-test gauntlet at <2/5, escalate to founder. If two consecutive waves fail at <3/5, pause and require founder voice authoring per original Packet 35 plan.

---

## Risk register

| # | Risk | Mitigation |
|---|---|---|
| R1 | Codex-authored patterns sound generic, fail expert-consultant gauntlet | Quality guardrails explicit; ≥3/5 gauntlet threshold; reversion clause if two waves fail |
| R2 | Customer asks "who authored this?" — answer can't be founder | Provenance tagging makes the answer transparent: "Codex-authored against the AbarVa quality framework. Customer can extend privately or commission custom authoring." |
| R3 | Counter-intuitive reasoning weaker without founder voice | Acknowledged. Gauntlet threshold adjusted. K06 continuous learning loop (Packet 33) compounds quality over time as customer feedback feeds back |
| R4 | Healthcare advisor never onboards, healthcare quality stays at Codex-authored level | v1 ships per this amendment. Advisor-reviewed revision pass (Wave 5B.4) queued for future when advisor lands. v1 is sellable; advisor-reviewed v2 is "best-in-class" upsell |
| R5 | Customers expect "founder-curated" depth | Reframe in sales conversations: "We provide industrial-grade out-of-box vertical depth. Your team + ours can extend with your proprietary patterns at customer-private-tier or via paid PS engagement." |
| R6 | Investor diligence questions the corpus authorship | Provenance tagging answers transparently. Plus: the moat isn't who authored each pattern — it's the methodology, format, and ability to industrialize at 5,000/vertical/4-weeks. That story is true regardless. |

---

## Acceptance for this amendment

- [ ] Committed to repo (this file)
- [ ] Codex Master Backlog references Sections 5A, 5B, 5C in critical path
- [ ] Provenance tagging schema added to `corpus_patterns` table (small migration)
- [ ] Quality guardrails per section live in Codex's authoring instructions
- [ ] Trust ladder authority class extended for content authoring per "Trust Ladder Implications" section above
- [ ] Section 11.5 customer custom pattern authoring captured in Founder Backlog as standalone item

---

## Document control

- **Version:** Codex Master Backlog Amendment A v1
- **Date:** 2026-05-29
- **Author:** Anand + Claude
- **Status:** Proposed — awaits commit + PR + founder approval
- **Companion:** `CODEX_MASTER_BACKLOG_2026-05-29.md`, ADR-0001 (with Amendment A1), Packet 31 amendments
- **Refresh:** When healthcare advisor onboards (queues Wave 5B.4); when customer custom authoring v2 ships (updates Section 11.5)

---

*End of Amendment A. Codex authors at scale; founder spot-checks at wave boundaries; customer custom authoring becomes the upsell + commercial hedge.*
